Results 61 to 70 of about 1,629 (148)

An Unusual Manifestation of Blastic Plasmacytoid Dendritic Cell Neoplasm as a Testicular Tumor

open access: yesCase Reports in Pathology, 2019
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy arising from precursors of plasmacytoid dendritic cells that represent less than 1% of hematological malignancies.
Daniel M. Pak, Maria S. Tretiakova
doaj   +1 more source

Acute Myeloid Leukemia With Plasmacytoid Differentiating Cutaneous Lesions: A Case of Double Identity or Active Transformation

open access: yeseJHaem
Introduction Acute myeloid leukemia (AML) with plasmacytoid dendritic cell differentiation (pDC‐AML) is a newly described subtype of leukemia with features resembling blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Benjamin J. Lee   +5 more
doaj   +1 more source

Reduced intensity allogeneic stem cell transplant for treatment of blastic plasmacytoid dendritic cell neoplasm

open access: yesHematology Reports, 2014
Blastic plasmacytoid dendritic cell neoplasm is a rare, aggressive tumor characterized by skin and/or marrow infiltration by CD4+ CD56+ cells. Historically, the tumor was variably thought to arise from either monocytes, T cells or NK cells giving rise to
Anand Lokare   +7 more
doaj   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm

open access: yesKansas Journal of Medicine, 2014
Introduction Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, highly aggressive hematopoietic malignancy. It manifests as cutaneous and bone marrow involvement and leukemic spread. It represents 0.7% of primary cutaneous lymphomas. Recently, it was established as a distinct entity.
Rami Jabbour   +3 more
openaire   +2 more sources

Blastic plasmacytoid dendritic cell neoplasm presenting as leukemia without cutaneous involvement in a 25 years male patient: Unusual presentation of a rare entity

open access: yesIndian Journal of Pathology and Microbiology, 2015
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive neoplasm classified under "acute myeloid leukemia (AML) and related precursor neoplasm" by current WHO classification.
Sumaira Qayoom   +3 more
doaj   +1 more source

Dermatoscopic features of blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia
Blastic plasmacytoid dendritic cell neoplasm is a malignant, aggressive, and rare tumor arising from plasmacytoid dendritic cell precursors. Because of its infrequency, information on clinical features and best treatment options is still lacking ...
Daniel Argüello-Ruiz   +2 more
doaj  

Blastic plasmacytoid dendritic cell neoplasm mimicking dermatomyositis

open access: yesJAAD Case Reports, 2023
Christopher J. Fay, BA   +4 more
doaj   +1 more source

Pseudo-Rosette-Forming Blastic Plasmacytoid Dendritic Cell Neoplasm

open access: yesTurkish Journal of Hematology, 2020
Praveen Sharma, Shano Naseem
doaj   +1 more source

Plenary Abstracts Session & Oral Presentations

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Home - About - Disclaimer - Privacy